Home
Novo Holdings

Novo Holdings Market Share Analysis for March 2026

Novo Holdings A/S is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2023 was worth almost DKK 1,114 billion Danish Kroner.

Finance > Investing

Domainnovoholdings.dk

Year Founded1999

Employees51 - 200

Annual Revenue> $1B

Novo Holdings

Novo Holdings (including company regionals)

novoholdings.dk

See more website traffic and engagement information

Novo Holdings Revenue up to March 2026 is > 1B

revenue generated by Novo Holdings top domains

Novo Holdings top domains revenue over 3 years

Revenue for Novo Holdings top domains

novoholdings.dk> 1B

See more with Sales Intelligence

Total visits to Novo Holdings's top domains

Understand Novo Holdings market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

novoholdings.dk39.2K

See more with Sales Intelligence

Avg. visit duration in Novo Holdings's top domains

Analyze Novo Holdings engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

novoholdings.dk00:00:41

See more with Sales Intelligence

Avg. pageviews on Novo Holdings's top domains

See how Novo Holdings keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

novoholdings.dk2.11

See more with Sales Intelligence

Novo Holdings top competitors by domain

Top similar sites in March 2026, ranked by their affinity

novonordisk.comCompany NameNovo NordiskEmployees> 10001HQDenmark, BagsvaerdAnnual revenue> $1BTotal visits1.4MHealth > Health - Other

Top technologies used by Novo Holdings

These are the website technologies, by industry, used by Novo Holdings top domains

Advertising (7)

DoubleClick

Content Management System (5)

WordPress

Conversion & Analytics (4)

Google Analytics

Widget (4)

Google Maps

More Technologies

8

See all

News & Signals from Novo Holdings

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovo Holdings expands offices in South Korea, Eastern Asia, Asia.Novo Holdings is expanding its presence in South Korea's healthcare and life sciences sector as part of its long-term commitment to investing in Asia, Novo announces in a press release.

NewsNovo Holdings invested into Coultreon Biopharma $125M in Series A on Apr 28th '26.Novo Holdings today announces its participation in an oversubscribed $125 million Series A financing round in Coultreon Biopharma (formerly Onco3R Therapeutics), a Belgium-based biotechnology company founded on a strong scientific platform originating from Galapagos, focused on developing best-in-class therapies for autoimmune diseases.

NewsNovo Holdings invests into Antag Therapeutics ApS $94.4M in Series A.Antag Therapeutics has raised €80 million in a Series A financing led by Versant Ventures with participation from Novo Holdings, SR One, Dawn Biopharma, Pictet, Longview Ventures, and the Export and Investment Fund of Denmark (EIFO).